Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Synchronized versus routine hCG timing for intrauterine insemination in infertile women
IRCT20120215009014N286Phase 3Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Jul 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of human chorionic gonadotropin in female infertility (2 arms), sponsored by Hamadan University of Medical Sciences. Primary endpoint: Success of intrauterine insemination. Started Jul 2019; status: completed.
02
Drugs
human chorionic gonadotropin
03
Conditions
female infertility
Beyond the preview
Go deeper on IRCT20120215009014N286.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120215009014N286.